{"id":15985,"date":"2026-01-01T12:11:27","date_gmt":"2026-01-01T06:41:27","guid":{"rendered":"https:\/\/www.torusdigital.com\/toruscope\/?p=15985"},"modified":"2026-01-01T12:11:27","modified_gmt":"2026-01-01T06:41:27","slug":"stocks-to-buy-today-january-1-2026","status":"publish","type":"post","link":"https:\/\/www.torusdigital.com\/toruscope\/news\/stocks-to-buy-today-january-1-2026\/","title":{"rendered":"Stocks to Buy Today: January 1, 2026"},"content":{"rendered":"

[vc_section el_id=”blog-inner-layout”][vc_row overlay_dotted=””][vc_column el_class=”blog_primary”][vc_row_inner][vc_column_inner][vc_column_text css=””]At the start of the New Year, Indian equity markets are entering 2026 on a constructive footing after closing higher on the final trading session of 2025. On 31 December 2025, the Nifty 50 advanced 0.74% to close at 26,129.60, while the BSE Sensex gained 0.64% to settle at 85,220.60, supported by broad-based buying across sectors.<\/p>\n

Market participants remain optimistic about the medium-term outlook. Indian equities are expected to deliver steady growth in 2026, aided by improving corporate earnings visibility, gradual recovery in private sector investment and supportive government policies. In the near term, markets may remain range-bound due to thin holiday volumes, but selective stock-specific buying is likely to continue.<\/p>\n

Against this backdrop, here are some stocks that investors can track closely in today\u2019s trading session.<\/p>\n

<\/span>Caplin Point Laboratories Ltd. [NSE: CAPLIPOINT]<\/strong><\/span><\/h2>\n

Caplin Point Laboratories remains a fundamentally strong midcap pharmaceutical company with a differentiated presence in emerging markets. The company continues to benefit from its focus on niche injectable and dosage form segments, which support stable margins and steady cash flows. Its conservative balance sheet, consistent return ratios and disciplined capital allocation provide resilience during volatile market phases.<\/p>\n

With the stock trading well below its 52 week high, the current price zone offers investors an opportunity to accumulate a quality pharma name with long term growth visibility driven by capacity expansion, product launches and regulated market entry over time.<\/p>\n

<\/span>Key Details<\/strong><\/span><\/h3>\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Particulars<\/strong><\/td>\nData<\/strong><\/td>\n<\/tr>\n<\/thead>\n
Closing Price (as of Dec 31, 2025)<\/td>\n\u20b91,838.10<\/td>\n<\/tr>\n
Average Trading Volume<\/td>\n64.90K<\/td>\n<\/tr>\n
Company Type<\/td>\nMidcap<\/td>\n<\/tr>\n
Market Cap<\/td>\n\u20b913,904 crore<\/td>\n<\/tr>\n
P\/E Ratio<\/td>\n23.70<\/td>\n<\/tr>\n
Dividend Yield<\/td>\n0.33%<\/td>\n<\/tr>\n
Day range<\/td>\n\u20b91,822.00 – \u20b91,847.20<\/td>\n<\/tr>\n
52-week range<\/td>\n\u20b91,599.00 – \u20b92,625.95<\/td>\n<\/tr>\n
Beta<\/td>\n1.56<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

<\/span>Hitachi Energy India Ltd. [NSE: POWERINDIA]<\/strong><\/span><\/h2>\n

Hitachi Energy India is a key beneficiary of India\u2019s power transmission, renewable integration and grid modernisation themes. Strong execution capabilities, a robust order book and increasing focus on high voltage direct current and grid automation projects support long term earnings visibility.<\/p>\n

While valuations remain elevated, the company\u2019s leadership position in critical power infrastructure and continued policy thrust on energy transition justify investor interest. Any near term consolidation is often viewed as an accumulation opportunity for investors with a long term horizon.<\/p>\n

<\/span>Key Details<\/strong><\/span><\/h3>\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Particulars<\/strong><\/td>\nData<\/strong><\/td>\n<\/tr>\n<\/thead>\n
Closing Price (as of Dec 31, 2025)<\/td>\n\u20b918,310.00<\/td>\n<\/tr>\n
Average Trading Volume<\/td>\n119.37K<\/td>\n<\/tr>\n
Company Type<\/td>\nLargecap<\/td>\n<\/tr>\n
Market Cap<\/td>\n\u20b981,679 crore<\/td>\n<\/tr>\n
P\/E Ratio<\/td>\n111.61<\/td>\n<\/tr>\n
Dividend Yield<\/td>\n0.03%<\/td>\n<\/tr>\n
Day range<\/td>\n\u20b918,205.00 – \u20b918,420.00<\/td>\n<\/tr>\n
52-week range<\/td>\n\u20b98,801.00 – \u20b922,840.00<\/td>\n<\/tr>\n
Beta<\/td>\n0.97<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

<\/span>Oracle Financial Services Software Ltd. [NSE: OFSS]<\/strong><\/span><\/h2>\n

Oracle Financial Services Software offers steady exposure to global banking technology spending. The company benefits from long term contracts, high client stickiness and strong parentage, which together provide earnings stability even during periods of global uncertainty.<\/p>\n

The stock\u2019s attractive dividend yield and cash-rich balance sheet make it appealing for investors seeking a combination of income and steady growth. As global banks continue investing in core banking upgrades and digital transformation, OFSS remains well-positioned.<\/p>\n

<\/span>Key Details<\/strong><\/span><\/h3>\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Particulars<\/strong><\/td>\nData<\/strong><\/td>\n<\/tr>\n<\/thead>\n
Closing Price (as of Dec 31, 2025)<\/td>\n\u20b97,687.00<\/td>\n<\/tr>\n
Average Trading Volume<\/td>\n109.68K<\/td>\n<\/tr>\n
Company Type<\/td>\nLargecap<\/td>\n<\/tr>\n
Market Cap<\/td>\n\u20b966,638 crore<\/td>\n<\/tr>\n
P\/E Ratio<\/td>\n28.15<\/td>\n<\/tr>\n
Dividend Yield<\/td>\n3.43%<\/td>\n<\/tr>\n
Day range<\/td>\n\u20b97,642.00 – \u20b97,714.00<\/td>\n<\/tr>\n
52-week range<\/td>\n\u20b97,038.00 – \u20b912,879.95<\/td>\n<\/tr>\n
Beta<\/td>\n1.54<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

<\/span>Sumitomo Chemical India Ltd. [NSE: SUMICHEM]<\/strong><\/span><\/h2>\n

Sumitomo Chemical India operates across agri inputs, speciality chemicals and environmental health solutions. The company benefits from strong parent backing, a diversified product portfolio and improving domestic demand trends.<\/p>\n

Although the stock has seen some recent pressure, its long-term growth drivers remain intact, supported by rising agri productivity needs and expanding speciality chemical applications. Gradual margin improvement and volume recovery could act as triggers over the medium term.<\/p>\n

<\/span>Key Details<\/strong><\/span><\/h3>\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Particulars<\/strong><\/td>\nData<\/strong><\/td>\n<\/tr>\n<\/thead>\n
Closing Price (as of Dec 31, 2025)<\/td>\n\u20b9471.00<\/td>\n<\/tr>\n
Average Trading Volume<\/td>\n193.49K<\/td>\n<\/tr>\n
Company Type<\/td>\nMidcap<\/td>\n<\/tr>\n
Market Cap<\/td>\n\u20b923,303 crore<\/td>\n<\/tr>\n
P\/E Ratio<\/td>\n42.96<\/td>\n<\/tr>\n
Dividend Yield<\/td>\n0.26%<\/td>\n<\/tr>\n
Day range<\/td>\n\u20b9465.00 – \u20b9471.00<\/td>\n<\/tr>\n
52-week range<\/td>\n\u20b9432.20 – \u20b9665.00<\/td>\n<\/tr>\n
Beta<\/td>\n0.83<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

<\/span>Avenue Supermarts Ltd. [NSE: DMART]<\/strong><\/span><\/h2>\n

Avenue Supermarts continues to be one of India\u2019s strongest retail franchises, driven by efficient cost control, high inventory turnover and consistent store-level profitability. Despite short term market volatility, the company\u2019s long term growth story remains anchored in rising consumption, store expansion and strong private label penetration.<\/p>\n

While valuations remain premium, DMart\u2019s execution track record and balance sheet strength keep it firmly on investors\u2019 watchlists for long term compounding.<\/p>\n

<\/span>Key Details<\/strong><\/span><\/h3>\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Particulars<\/strong><\/td>\nData<\/strong><\/td>\n<\/tr>\n<\/thead>\n
Closing Price (as of Dec 31, 2025)<\/td>\n\u20b93,782.20<\/td>\n<\/tr>\n
Average Trading Volume<\/td>\n335.51K<\/td>\n<\/tr>\n
Company Type<\/td>\nLargecap<\/td>\n<\/tr>\n
Market Cap<\/td>\n\u20b92.44 lakh crore<\/td>\n<\/tr>\n
P\/E Ratio<\/td>\n89.64<\/td>\n<\/tr>\n
Dividend Yield<\/td>\n–<\/td>\n<\/tr>\n
Day range<\/td>\n\u20b93,746.10 – \u20b93,808.00<\/td>\n<\/tr>\n
52-week range<\/td>\n\u20b93,340.00 – \u20b94,949.50<\/td>\n<\/tr>\n
Beta<\/td>\n0.73<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

<\/span>Conclusion<\/strong><\/span><\/h2>\n

Stock market investments do not guarantee returns, and market conditions can change rapidly. Investors should focus on companies with strong fundamentals, clear earnings visibility and sector tailwinds when making trading or investment decisions. High liquidity stocks with defined support levels are often better suited for short-term strategies, while fundamentally strong businesses reward patient long-term investors.<\/p>\n

Risk management remains essential. Use appropriate position sizing, set stop losses and align trades with your risk tolerance and investment horizon.<\/p>\n

Just starting your investment journey? Open a Demat Account with Torus Digital today and take your first step into the stock market with confidence.[\/vc_column_text][vc_column_text css=””][\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_id=”share_rating”][vc_column_inner width=”1\/2″][vc_column_text css=””]<\/p>\n

Rate this article<\/h6>\n